EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 4

Ginger Zingiber officinale Roscoe

Ginger is native to the warm parts of Asia and is now grown in parts of South America, Africa and the Middle East. Its rhizome (underground stem) is used in food and for health purposes.

Category
Botanical
Part used
Rhizome
Strongest evidence
B Some positive trials
Reviewed
2026-10-28

Class 1 Well studied in people. A 2014 systematic review and meta-analysis (Nutrition Journal) included 12 RCTs (1,278 pregnant women) of orally taken ginger versus placebo, vitamin B6 or dimenhydrinate for nausea and vomiting of pregnancy. [4]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied5 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Ginger does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Ginger, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Nausea and vomiting of pregnancyBNCCIH states research shows ginger may be helpful; most studies tested dietary supplements rather than foods. [1]
Motion sicknessCNCCIH states most studies of ginger for motion sickness haven't shown it to be helpful. [1]
Chemotherapy-related and postoperative nauseaCUncertain whether ginger adds benefit to standard treatment for chemotherapy nausea, or helps nausea after surgery. [1]
Menstrual cramp severityCNCCIH states research suggests ginger supplements might reduce the severity of menstrual cramps. [1]
Knee osteoarthritis symptomsCOral supplements might help, but much of the research is of poor quality; topical ginger has not been shown to help. [1]

Main constituents: Volatile oil (2% to 3%) and pungent phenolic compounds, including gingerols, shogaols, gingerdiols and diarylheptanoids; about 50% starch by weight [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Typical dose is up to the equivalent of 1000 mg of dried powdered extract daily, given one to three times daily. [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated February 10, 2024).

    Details and sources
  • Pregnancy and breastfeeding
    EU monograph: a moderate amount of data on pregnant women (between 300 and 1000 pregnancy outcomes) indicates no malformative or feto/neonatal …

    3 statements in the profile.

    Details and sources
  • Interactions with medicines
    3 listed

    Anticoagulants, antiplatelet drugs and NSAIDs; Blood sugar-lowering drugs and insulin; Tacrolimus and cyclosporine

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    3 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    EU herbal monograph on Zingiber officinale Roscoe, rhizoma (EMA/HMPC/885789/2022, Revision 1, 7 May 2025): well-established use for nausea and …

    Details and sources
  • Used safely in many research studies as an oral supplement; may also be safe topically. [1]
  • Possible abdominal discomfort, heartburn, diarrhea, and mouth and throat irritation. [1]
  • Supplements during pregnancy may be safe; consult a clinician. Little is known about use while breastfeeding. [1]
  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury); no hepatotoxicity reported in more than 100 clinical trials. [2]
Quality

Identity, quality and standardization

  • Dose varies with the concentration and purity of the product. [2]
Regulation

Regulatory status

  • US: herbal products for oral use are often marketed as dietary supplements, which, unlike drugs, are not approved by the FDA before sale; manufacturers are responsible for safety and labeling. [1]
  • EU: an EU herbal monograph covers well-established use of a specific preparation for preventing nausea and vomiting in motion sickness, and traditional use for several mild complaints. [3]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Gingerols and shogaols, with gingerdiols and diarylheptanoids (non-volatile pungent compounds; the volatile oil is 2% to 3%) Phenolic compounds (alkylphenols) and diarylheptanoids [P7]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 3 entries naming ginger (Zingiber officinale), all within multi-ingredient botanical combinations (earliest NDI 192 submitted 2002-12-09; most recent NDI 954 submitted 2016-10-28). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of ginger was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of ginger (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated February 10, 2024). [P7]

Interactions with medicines

  • Anticoagulants, antiplatelet drugs and NSAIDs: Ginger can inhibit thromboxane formation and platelet aggregation, so combined use may increase bleeding risk, although a systematic review found the evidence inconclusive. [P8]
  • Blood sugar-lowering drugs and insulin: Ginger may cause additive reductions in blood glucose; clinical relevance is not known. [P8]
  • Tacrolimus and cyclosporine: Pretreatment with ginger increased tacrolimus plasma levels, and ginger decreased cyclosporine blood concentrations in vivo; clinical relevance is not known. [P8]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • IUCN Red List: Data Deficient (DD), via GBIF species API, retrieved 2026-10-29 [P5]
  • Ginger is native to the warm parts of Asia and is now grown in parts of South America, Africa and the Middle East. [P6]

Absorption in people

  • In 27 healthy volunteers given 100 mg to 2.0 g ginger, no free 6-, 8-, 10-gingerol or 6-shogaol was detected in plasma; they circulated as glucuronide and sulfate conjugates. At 2.0 g, conjugate Cmax values were 0.15–0.85 µg/mL, tmax about 65–75 minutes and half-lives under 2 hours. [P9]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU herbal monograph on Zingiber officinale Roscoe, rhizoma (EMA/HMPC/885789/2022, Revision 1, 7 May 2025): well-established use for nausea and vomiting of motion sickness, adults, 1–2 g powdered rhizome 1 hour before travel; traditional use for motion sickness, adolescents and adults, 500–750 mg powdered rhizome half an hour before traveling. [P10]

Pregnancy and breastfeeding

  • EU monograph: a moderate amount of data on pregnant women (between 300 and 1000 pregnancy outcomes) indicates no malformative or feto/neonatal toxicity of ginger root; as a precaution it is preferable to avoid use during pregnancy; use during lactation is not recommended. [P10]
  • NCCIH: use of ginger dietary supplements during pregnancy may be safe; little is known about use while breastfeeding. [P6]
  • LiverTox: ginger has not been linked to fetal toxicity or teratogenesis. [P7]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. GBIF species API: IUCN Red List category for Zingiber officinale, 2026-10-29. api.gbif.org
  6. NCCIH. Ginger: Usefulness and Safety (Last Updated: February 2025), 2025-02. nccih.nih.gov
  7. NIH LiverTox (NIDDK). Ginger (Last Update: February 10, 2024), 2024-02-10. ncbi.nlm.nih.gov
  8. Memorial Sloan Kettering Cancer Center. About Herbs: Ginger (last updated June 2, 2022), 2022-06-02. mskcc.org
  9. Zick SM, et al. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17(8):1930-1936 (PMID 18708382), 2008-08. pubmed.ncbi.nlm.nih.gov
  10. European Medicines Agency, HMPC. European Union herbal monograph on Zingiber officinale Roscoe, rhizoma, EMA/HMPC/885789/2022 (Final, Revision 1, 7 May 2025), 2025-05-07. ema.europa.eu
Sources

Sources

  1. NCCIH. Ginger: Usefulness and Safety (Last Updated: 2025-02), 2025-02. nccih.nih.gov
  2. NIH LiverTox (NIDDK). Ginger (Last Update: 2024-02-10), 2024-02-10. ncbi.nlm.nih.gov
  3. European Medicines Agency, HMPC. Zingiberis rhizoma (ginger) - herbal medicinal product, 2026-03-12. ema.europa.eu
  4. Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J 2014;13:20 (PMID 24642205), 2014-03-19. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.